Shangyu Jingxin Pharmaceutical Co., Ltd.'s Rosuvastatin Calcium API Obtained CEP Certificate

- Mar 15, 2021-

                                   Recently, Shangyu Jingxin, a wholly-owned subsidiary of Jingxin Pharmaceuticals, received the European Pharmacopoeia Applicability Certificate (“CEP Certificate”) for Rosuvastatin Calcium API issued by the European Drug Quality Administration (“EDQM”).